Canada
· Delayed Price · Currency is CAD Aptose Biosciences Statistics
Total Valuation
TSX:APS has a market cap or net worth of CAD 6.05 million. The enterprise value is 12.38 million.
| Market Cap | 6.05M |
| Enterprise Value | 12.38M |
Important Dates
The last earnings date was Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:APS has 2.55 million shares outstanding. The number of shares has increased by 295.92% in one year.
| Current Share Class | 2.55M |
| Shares Outstanding | 2.55M |
| Shares Change (YoY) | +295.92% |
| Shares Change (QoQ) | +79.40% |
| Owned by Insiders (%) | 0.31% |
| Owned by Institutions (%) | 7.40% |
| Float | 2.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.57 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.40 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.32 |
Financial Position
The company has a current ratio of 1.10
| Current Ratio | 1.10 |
| Quick Ratio | 0.75 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.34 |
| Interest Coverage | -75.46 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -135.46% |
| Return on Invested Capital (ROIC) | -977.13% |
| Return on Capital Employed (ROCE) | -1,911.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.36M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.06% in the last 52 weeks. The beta is 1.09, so TSX:APS's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | +49.06% |
| 50-Day Moving Average | 3.59 |
| 200-Day Moving Average | 1.35 |
| Relative Strength Index (RSI) | 41.29 |
| Average Volume (20 Days) | 6,610 |
Short Selling Information
The latest short interest is 6,975, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 6,975 |
| Short Previous Month | 10,084 |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.05% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -31.56M |
| Pretax Income | -30.66M |
| Net Income | -30.66M |
| EBITDA | -31.53M |
| EBIT | -31.56M |
| Earnings Per Share (EPS) | -27.35 |
Balance Sheet
The company has 6.82 million in cash and 13.15 million in debt, giving a net cash position of -6.33 million or -2.48 per share.
| Cash & Cash Equivalents | 6.82M |
| Total Debt | 13.15M |
| Net Cash | -6.33M |
| Net Cash Per Share | -2.48 |
| Equity (Book Value) | -10.63M |
| Book Value Per Share | -4.16 |
| Working Capital | 935,715 |
Cash Flow
In the last 12 months, operating cash flow was -38.82 million and capital expenditures -7,187, giving a free cash flow of -38.83 million.
| Operating Cash Flow | -38.82M |
| Capital Expenditures | -7,187 |
| Free Cash Flow | -38.83M |
| FCF Per Share | -15.21 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:APS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -295.92% |
| Shareholder Yield | n/a |
| Earnings Yield | -506.89% |
| FCF Yield | -641.87% |
Stock Splits
The last stock split was on February 26, 2025. It was a reverse split with a ratio of 0.0333333.
| Last Split Date | Feb 26, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0333333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |